High Purity Peptide for Weight Management: Mazdutide Dual Receptor Agonist
Experience advanced weight loss with our highly pure Mazdutide, a powerful GLP-1 and glucagon receptor dual agonist.
Get a Quote & SampleProduct Core Value

Mazdutide Peptide
Mazdutide is a cutting-edge synthetic peptide analogue of mammalian oxyntomodulin, designed to act as a potent once-weekly GLP-1 and glucagon receptor dual agonist. This advanced compound plays a crucial role in managing weight loss by targeting key metabolic pathways. Its exceptional purity of over 99% ensures efficacy and reliability for therapeutic applications.
- Discover the benefits of GLP-1 receptor agonist for weight loss, offering a novel approach to metabolic health.
- Explore the mechanism of a dual agonist peptide for weight management, providing comprehensive metabolic support.
- Benefit from the high purity (>99%) of Mazdutide, ensuring consistent and reliable performance in research and clinical settings.
- Inquire about pharmaceutical intermediate Mazdutide for your formulation needs, meeting stringent quality standards.
Key Advantages
Enhanced Efficacy
Leverage the power of a once-weekly weight loss peptide like Mazdutide for improved patient compliance and sustained results.
Superior Purity
Our synthetic peptide analogue Mazdutide boasts a purity of >99%, making it an ideal choice for demanding applications and buy Mazdutide online for research.
Dual Receptor Action
Experience the targeted action of a dual agonist peptide, optimizing metabolic control and contributing to effective weight management strategies.
Key Applications
Obesity Treatment
Utilize the effectiveness of weight loss peptides Mazdutide for comprehensive obesity treatment protocols.
Metabolic Health
Support metabolic health with this advanced GLP-1 receptor agonist for weight loss, impacting energy balance and glucose regulation.
Pharmaceutical Research
Investigate the potential of pharmaceutical intermediate Mazdutide in developing new therapeutic agents.
Clinical Trials
Source high-quality Mazdutide CAS 2259884-03-0 for use in clinical trials focused on metabolic and weight management interventions.